Editorial Nutritional Modulators in Chronic Heart Failure
نویسندگان
چکیده
منابع مشابه
Nutritional intake and oxidative stress in chronic heart failure.
BACKGROUND AND AIMS Patients with chronic heart failure (CHF) are known to be at risk of malnutrition, and cardiac cachexia is an adverse prognostic indicator. The aim of this study was to determine the dietary adequacy of CHF patients compared with Dietary Reference Values, to compare the nutritional intake and status of CHF patients to a healthy comparison group, and finally to determine whet...
متن کاملIs nutritional intake adequate in chronic heart failure patients?
OBJECTIVES The goal of this study was to investigate the nutrition adequacy and energy availability for physical activity in free-living, clinically stable patients with chronic heart failure (CHF). BACKGROUND Little information exists regarding the nutrition adequacy and alimentary habits of patients with clinically stable CHF. We hypothesized that CHF patients have an inadequate intake of c...
متن کاملEditorial / - Blocker Treatment for Chronic Heart Failure The Frog Prince
In 1975, Waagstein and colleagues1 published several case reports of patients with heart failure and tachycardia who clinically improved after long-term administration of p-adrenergic antagonists. These initial reports were met with substantial skepticism, since p-blocking agents are negatively inotropic and chronotropic. Their use for treatment of heart failure is counterintuitive and demands ...
متن کاملSoluble guanylate cyclase modulators in heart failure.
This review summarizes the role of soluble guanylate cyclase (sGC)-cyclic guanosine 3', 5'-monophosphate pathways in heart failure and several new drugs that modify guanylate cyclase. The sGC activators and stimulators as modulators of sGC are promising drugs in the therapy for decompensated heart failure and pulmonary hypertension. Cinaciguat is a nitric oxide (NO)-independent direct activator...
متن کاملchronic pain in chronic heart failure: a review article
heart failure (hf) is one of the main causes of death and disability in the world. the prevalence of hf in developed countries is between 1% and 2% of the adult population and approximately between 6% and 10% in the elderly, giving rise to high costs of care and treatment. indeed, in the united states, the direct and indirect costs exceeded 23 billion dollars in 2002. hf is typically character...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Open Nutraceuticals Journal
سال: 2015
ISSN: 1876-3960
DOI: 10.2174/1876396001508010001